Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-02-26 @ 7:49 PM
Study NCT ID:
NCT00565656
Status:
TERMINATED
Last Update Posted:
2011-12-08
First Post:
2007-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts
Sponsor:
Centre Hospitalier Universitaire de Nice
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
06-PP-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None